T follicular helper cells: linking cancer immunotherapy and immune-related adverse events | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: T follicular helper cells: linking cancer immunotherapy and immune-related adverse events - August 01, 2021

XML

Hypothesis

T follicular helper cells: linking cancer immunotherapy and immune-related adverse events

Online download statistics by month:

Online download statistics by month: June 2021 to April 2023

	Abstract	Full	Pdf
Jun 2021	605	608	147
Jul 2021	246	246	46
Aug 2021	175	174	65
Sep 2021	115	115	49
Oct 2021	97	97	60
Nov 2021	107	105	27
Dec 2021	117	120	32
Jan 2022	83	89	27
Feb 2022	60	63	32
Mar 2022	70	82	32
Apr 2022	100	107	32
May 2022	112	116	39
Jun 2022	101	106	35
Jul 2022	86	86	26
Aug 2022	87	95	35
Sep 2022	76	77	28
Oct 2022	303	327	78
Nov 2022	139	145	40
Dec 2022	75	77	27
Jan 2023	257	259	61
Feb 2023	108	108	24
Mar 2023	76	80	37
Apr 2023	58	58	18
Total	3253	3340	997